Follow us for updates
© 2021 reportr.world
Read the Story →

Russia's Gamaleya Seeks FDA Nod for Single-Dose Sputnik Light

It has 79.4% efficacy.
by Pia Regalado
Just now
Photo/s: Jerome Ascaño
Shares

The Food and Drug Administration said Tuesday it was evaluating Gamaleya's Sputnik Light, a single-dose COVID-19 vaccine, for possible emergency use in the Philippines.

The vaccine, which boasts a 79.4% efficacy based on analyzed data from Russia's mass vaccination program, is said to be effective against all strains of the coronavirus. The two-dose Sputnik V has Emergency Use Authorization or EUA from Filipino regulators.

"Ito po ‘yung single dose na Sputnik na nag-apply na rin po actually dito sa atin ng EUA at pinag-aaralan na rin po ng ating mga vaccine experts," FDA Director General Eric Domingo said told President Rodrigo Duterte during a Cabinet briefing aired Monday night.

Russia authorized the one-shot version of its flagship Sputnik V vaccine in May 2021. Sputnik Light will cost less than $10 (about P500) per dose, the Russian Direct Investment Fund (RDIF) said.

Continue reading below ↓
Continue reading below ↓
Recommended Videos

Reportr is now on Quento. Download the app or visit the Quento website for more articles and videos from Reportr and your favorite websites.

Latest Headlines
Read Next
Recent News
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to reportr.world newsletter, you agree to our Terms of Service and Privacy Policy.